Mavoglurant developmental code name AFQ-056 is an experimental drug candidate for the treatment of fragile X syndrome. Reference standards of Mavoglurant API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.
Mavoglurant
Catalogue No.:PA 13 3110000
CAS :
Molecular Formula : C19H23NO3
Molecular Weight : 313.4
Mavoglurant D3
Catalogue No.:PA STI 089821
Molecular Formula : C19H20D3NO3
Molecular Weight : 316.42
I accept terms and conditions
Message sent successfully!! We will get back to you shortly ....
